financetom
Business
financetom
/
Business
/
--Goldman Sachs Group Plans to Increase Dividend to $3 per Share From $2.75, Effective July 1
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Goldman Sachs Group Plans to Increase Dividend to $3 per Share From $2.75, Effective July 1
Jul 1, 2024 3:40 AM

06:04 AM EDT, 07/01/2024 (MT Newswires) --

Price: 453.73, Change: +1.41, Percent Change: +0.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Netflix Unusual Options Activity
Netflix Unusual Options Activity
Jun 28, 2024
Whales with a lot of money to spend have taken a noticeably bearish stance on Netflix ( NFLX ). Looking at options history for Netflix ( NFLX ) we detected 46 trades. If we consider the specifics of each trade, it is accurate to state that 19% of the investors opened trades with bullish expectations and 45% with bearish. From...
Lululemon Stock Dips After Nike's Q4 Report: What's Going On?
Lululemon Stock Dips After Nike's Q4 Report: What's Going On?
Jun 28, 2024
Lululemon Athletica Inc. ( LULU ) shares are trading lower Friday in sympathy with Nike, Inc. ( NKE ) which fell after reporting its quarterly earnings.  The Details: Nike ( NKE ) shares have fallen more than 20% Friday after the company reported worse-than-expected fourth-quarter revenue and weak forward guidance.  Nike's ( NKE ) CFO, Matthew Friend, revised the company's...
What's Going On With Moderna Stock Friday?
What's Going On With Moderna Stock Friday?
Jun 28, 2024
Moderna, Inc. ( MRNA ) stock is trending on Friday. The company announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion for its RSV vaccine. The Details: The RSV vaccine, mRNA-1345, is designed to protect adults aged 60 and older from respiratory disease caused by the RSV infection. As a result,...
Bluejay Diagnostics Closes $8.8 Million Public Offering
Bluejay Diagnostics Closes $8.8 Million Public Offering
Jun 28, 2024
01:19 PM EDT, 06/28/2024 (MT Newswires) -- Bluejay Diagnostics ( BJDX ) said it closed Friday an underwritten public offering of under 5.4 million common or prefunded units, with expected gross proceeds of roughly $8.8 million. Net proceeds will be used to repay $2.3 million in debt, finance clinical studies and other activities related to seeking US Food and Drugs...
Copyright 2023-2026 - www.financetom.com All Rights Reserved